• Trilaurin: Protocols for Lipid and Enzyme Workflows

  2026-08-16

  Trilaurin, also called Glycerol Tridodecanoate, is a water-insoluble long-chain triacylglycerol used as a lipid excipient, formulation component, and biocatalytic synthesis substrate. This guide addresses solvent selection, short-term stock preparation, particle-formulation workflows, and enzyme-reaction QC while defining why it should not be used as a direct aqueous reagent or stored routinely as a long-term solution.

• EPI-001 AR N-Terminal Domain Inhibitor Workflow

  2026-08-15

  EPI-001 provides a practical way to interrogate androgen receptor transcriptional control beyond the ligand-binding domain, with applications in prostate cancer and exploratory triple-negative breast cancer models. This workflow connects viability, AR expression, migration, and EMT readouts while highlighting solubility, vehicle, and assay-design controls.

• Gastrin I (Human) in Next-Gen GI Translation

  2026-08-14

  Gastrin I (human) offers a controlled way to interrogate CCK2 receptor signaling, proton pump activation, and gastric acid secretion while creating a disciplined bridge to hiPSC-derived intestinal organoids. This thought-leadership article outlines how translational researchers can connect receptor-level biology with gastrointestinal physiology studies, pharmacokinetic modeling, and gastrointestinal disorder research without overstating what current organoid evidence demonstrates.

• Chemerin–cNTS Signaling, Superoxide, and Blood Pressure

  2026-08-14

  The 2024 reference study identifies a chemerin–CMKLR1–NADPH oxidase pathway in the caudal nucleus tractus solitarius that raises sympathetic nerve activity, arterial pressure, and heart rate. Its receptor-dissection experiments further indicate that downstream signaling depends more strongly on PVN NMDA receptors than on AMPA/kainate receptors, refining the interpretation of central glutamatergic control of cardiovascular function.

• Interpreting In Vitro Cancer Drug Responses

  2026-08-13

  Hannah R. Schwartz’s 2022 dissertation distinguishes relative viability from fractional viability, showing that these metrics capture different components of an anticancer response: proliferative arrest and cell death. Its central practical contribution is a framework for interpreting response magnitude together with response timing, improving how in vitro drug studies describe mechanism and treatment effect.

• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-08-13

  Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be propagated, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte CYP and transporter activities, supporting more human-relevant pharmacokinetic testing than conventional models.

• Brefeldin A: From Trafficking Stress to Translation

  2026-08-12

  A translational research perspective on how Brefeldin A converts ER-to-Golgi trafficking disruption into measurable ER stress, cytoskeletal change, and apoptosis—and how those mechanisms can inform more rigorous cancer and endothelial biology studies.

• Resiniferatoxin (RTX): TRPV1 Research Guide

  2026-08-12

  Resiniferatoxin (RTX) is an ultra-potent TRPV1 agonist that produces calcium-dependent excitation followed by functional desensitization of TRPV1-positive sensory endings. Its selective action supports research on pain, neurogenic inflammation, and TRPV1-dependent biology, but route, exposure, and model-specific controls are essential.

• L1023 Anti-Cancer Compound Library for Targeted Screens

  2026-08-11

  Turn a 1,164-compound, pre-dissolved collection into a practical workflow for biomarker-led phenotypic screening, pathway interrogation, and hit validation. The approach connects PLAC1 biology in clear cell renal cell carcinoma with broader kinase, apoptosis, and mTOR-focused cancer research while emphasizing controls and troubleshooting.

• Alda 1: From Aldehyde Detox to Cardiac Repair

  2026-08-11

  Alda 1 is an ALDH2 activator that connects aldehyde detoxification with cardiac stress and repair biology. This article presents an assay-centered framework for interpreting ALDH2 activation across ischemia, pressure overload, and radiation injury models.

• Aurora A, SAM Metabolism, and Trained Immunity

  2026-08-10

  Li et al. identify Aurora kinase A as a regulator of β-glucan-trained immunity through the mTOR–FOXO3–GNMT axis, which preserves endogenous S-adenosylmethionine and active histone methylation. The work connects kinase signaling, metabolic state, chromatin accessibility, and inflammatory memory, while showing that Aurora A inhibition weakens β-glucan-associated tumor suppression in mice.

• Prednisone Workflows for Immunology Research

  2026-08-09

  Prednisone enables controlled studies of lymphocyte suppression, G1 arrest, and apoptosis in primary human immune cells. This practical guide combines dose-and-time assay design with digestion-aware analytical thinking to improve reproducibility and translational interpretation.

• Tetracycline Hydrochloride: Protocols & Use Cases

  2026-08-08

  Build more reliable bacterial growth-inhibition, translation, and skin microbiome workflows with Tetracycline Hydrochloride. This guide pairs practical assay conditions with controls that distinguish bacteriostatic growth arrest from irreversible killing and places the antibiotic alongside a contrasting ROS-driven therapeutic study.

• Sabutoclax: Pan-Bcl-2 Inhibitor Workflow

  2026-08-07

  Sabutoclax is a cell-permeable pan-Bcl-2 inhibitor for dissecting how anti-apoptotic signaling shapes cancer-cell survival. This workflow pairs growth, viability, and death measurements so researchers can distinguish cytostatic effects from true apoptosis induction in cancer cells.

• WM-8014: Precision KAT6A Inhibitor for Advanced Cancer Biolo

  2026-08-07

  WM-8014 stands out as a nanomolar-potency, selective KAT6A inhibitor enabling precise oncogene-induced senescence and cell cycle arrest assays with minimal cytotoxicity. This article guides researchers through optimized protocols, advanced applications, and troubleshooting strategies for leveraging WM-8014 in epigenetic and cancer biology research.

7784 records 3/519 page Previous Next 12345 下5页 Last page